Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent
Top Cited Papers
Open Access
- 1 July 2013
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 62 (3), 181-190
- https://doi.org/10.1016/j.jacc.2013.04.045
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trialThe Lancet, 2013
- Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trialThe Lancet, 2013
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysisThe Lancet, 2012
- Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent ImplantationCirculation, 2012
- Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialThe Lancet, 2011
- Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in JapanCardiovascular Intervention and Therapeutics, 2011
- Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participantsEuropean Heart Journal, 2011
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011